Current status of risk stratification methods in acute coronary syndromes

Current Cardiology Reports

Volumn 8, Issue 4, 2006, Pages 282-288

  See, Raphael ^b   De Lemos, James A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CD40 LIGAND; PLACENTAL GROWTH FACTOR; PREGNANCY ASSOCIATED PLASMA PROTEIN A; TROPONIN;

ACUTE CORONARY SYNDROME; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ATHEROSCLEROSIS; ECHOCARDIOGRAPHY; HEART FAILURE; HIGH RISK PATIENT; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; NONBIOLOGICAL MODEL; PREDICTION; PROTEIN ANALYSIS; PROTEIN FUNCTION; REVIEW; RISK MANAGEMENT; SENSITIVITY AND SPECIFICITY;

ALBUMINS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ANGIOGRAPHY; CREATININE; ENDOPEPTIDASES; HUMANS; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PREGNANCY PROTEINS; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; RISK ASSESSMENT; RISK FACTORS; TNF RECEPTOR-ASSOCIATED FACTOR 3; TROPONIN; TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PEPTIDES AND PROTEINS;

EID: 33745874372     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-006-0060-8     Document Type: Review

References (42)

1. McCaig LF, Burt CW: National Ambulatory Medical Care Survey: 2001 Emergency Department Summary. Advance Data from Vital and Health Statistics; No. 225. Hyattsville, MD: National Center for Health Statistics, 2003.
2. Goldman L, Weinberg M, Weisberg M, et al.: A computer derived protocol to aid in the diagnosis of emergency room patients with acute chest pain. N Engl J Med 1982, 307:588-596.
3. McCarthy BD, Beshansky JF, D'Agostino RB, et al.: Missed diagnoses of acute myocardial infarction in the emergency department: results from a multicenter study. Ann Emerg Med 1993, 22:579-582.
4. Pope JH, Aufderheide TP, Ruthazer R, et al.: Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med 2000, 342:1163-1170.
5. Antman EM, Cohen M, Bernink PJLM, et al.: The TIMI risk score for unstable angina/non-ST elevation MI. JAMA 2000, 284:835-842.
6. Granger CB, Goldberg RJ, Dabbous OH, et al., for the Global Registry of Acute Coronary Events Investigators: Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2003, 163:2345-2353.
7. Boersma E. Pieper KS, Steyerberg EW, et al., for the PURSUIT Investigators: Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. Circulation 2000, 101:2557-2567.
8. Goncalves PA, Ferreira J, Aguiar C, et al.: TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS. Eur Heart J 2005, 26:865-872.
9. Yan AT, Jong P, Yan RT, et al.: Clinical trial-derived risk model may not generalize to real-world patients with acute coronary syndrome. Am Heart J 2004, 148:1020-1027.
10. Gibson CM, Dumaine RL, Gelfand EV, et al.: Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13307 patients in five TIMI trials. Eur Heart J 2004, 25:1998-2005.
11. Cockroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16:31-41.
12. Levey AS, Bosch JP, Lewis JB, et al.: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130:461-470.
13. Levey AS, Greene T, Kusek JW, et al.: A simplified equation to predict glomerular filtration rate from serum creatinine [abstract]. J Am Soc Nephrol 2000, 11:155A.
14. Laterza OF, Price CP, Scott MG: Cystatin C: an improved estimator of glomerular filtration rate? Clin Chem 2002, 48:699-707.
15. Jernberg T, Lindahl B, James S, et al.: Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome. Circulation 2004, 110:2342-2348.
16. Srivathsan K, Showalter J, Wilkens J, et al.: Cardiovascular outcome in hospitalized patients with minimal troponin I elevation and normal creatine phosphokinase. Int J Cardiol 2004, 97:221-224.
17. Dokainish H, Pillai M, Murphy SA, et al.: Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease: a TACTICS-TIMI-18 substudy. J Am Coll Cardiol 2005, 45:19-24.
18. Maeda K, Tsutamoto T, Wada A, et al.: Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998, 135:825-832.
19. Abdullah SM, Khera A, Das SR, et al.: Relation of coronary atherosclerosis determined by electron beam computed tomography and plasma levels of N-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (The Dallas Heart Study). Am J Cardiol 2005, 96:1284-1289.
20. Bassan R, Potsch A, Maisel A, et al.: B-type natriuretic peptide: a novel early blood marker of acute myocardial infarction in patients with chest pain and no ST-segment elevation. Eur Heart J 2005, 26:234-240.
21. Schnabel R, Rupprecht HJ, Lackner KJ, et al.: Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study. Eur Heart J 2005, 26:241-249.
22. Kragelund C, Gronning B, Kober L, et al.: N-terminal pro-b-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 2005, 352:666-675.
23. Morrow DA, de Lemos JA, Blazing MA, et al.: Prognostic value of B-type natriuretic peptide during follow-up of patients with unstable coronary artery disease in the A to Z trial. JAMA 2005, 294:2866-2871.
24. Goldstein JA, Chandra HR, O'Neill WW. Relation of number of complex lesions to serum C-reactive protein levels and major adverse cardiovascular events at one year. Am J Cardiol 2005, 96:56-60.
25. Oltrona L, Ottani F, Galvani M, et al.: Clinical significance of a single measurement of troponin-I and C-reactive protein at admission in 1773 consecutive patients with acute coronary syndromes. Am Heart J 2004, 148:405-415.
26. Ray KK, Cannon CP, Cairns R, et al.: Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 Trial. J Am Coll Cardiol 2005, 46:1417-1424.
27. Bar-Or D, Lau E, Winkler JV: A novel assay for cobalt-albumin biding and its potential as a marker for myocardial ischemia - a preliminary report. J Emerg Med 2000, 19:311-315.
28. Roy D, Quiles J, Aldama G, et al.: Ischemia modified albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T. Int J Cardiol 2004, 97:297-301.
29. Abadiel JM, Blassingame CL, Bankson DD: Albumin cobalt binding assay to rule out acute coronary syndrome. Ann Clinical Lab Sci 2005, 35:66-72.
30. Jin Y, Nonoyama S, Morio T, et al.: Characterization of soluble CD40 ligand released from human activated platelets. J Med Den Sci 2001, 48:23-27.
31. Yan JC, Wu ZG, Zong RQ, et al.: Relation between upregulation of CD40 system and complex stenosis morphology in patients with acute coronary syndrome. Acta Pharmacol Sin 2004, 25:251-256.
32. de Lemos JA, Zirlik A, Schönbeck U, et al.: Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis: results from the Dallas Heart Study. Arterioscler Thromb Vasc Biol 2005, 25:2192-2196.
33. Bayes-Genis A, Conover CA, Overgaard MT, et al.: Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 2001, 345:1022-1029.
34. Heeschen C, Dimmeler S, Hamm CW, et al.: Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J Am Coll Cardiol 2005, 45:229-237.
35. Cosin-Sales J, Christiansen M, Kaminski P, et al.: Pregnancy-associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris. Circulation 2004, 109:1724-1728.
36. Carmeliet P, Moons L, Luttun A, et al.: Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 2001, 7:575-583.
37. Luttun A, Tjwa M, Moons L, et al.: Revascularization of ischemic tissues by PIGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med 2002, 8:831-840.
38. Heeschen C, Dimmeler S, Fichtlscherer, et al.: Prognostic value of placental growth factor in patients with acute chest pain. JAMA 2004, 291:435-441.
39. Komatsu S, Hirayama A, Omori Y, et al.: Detection of coronary plaque by computed tomography with a novel plaque analysis system, 'Plaque Map', and comparison with intravascular ultrasound and angioscopy. Circ J 2005, 69:72-77.
40. Inoue F, Sato Y, Matsumoto N, et al.: Evaluation of plaque texture by means of multislice computed tomography in patients with acute coronary syndrome and stable angina. Circ J 2004, 68:840-844.
41. Weston P, Alexander JH, Patel MR, et al.: Hand-held echocardiographic examination of patients with symptoms of acute coronary syndromes in the emergency department: the 30-day outcome associated with normal left ventricular wall motion. Am Heart J 2004, 148:1096-1101.
42. Korosoglou G, Labadze N, Hansen A, et al.: Usefulness of real-time myocardial perfusion imaging in the evaluation of patients with first time chest pain. Am J Cardiol 2004, 94:1225-1231.